Immediate Impact
57 standout
Citing Papers
Pre-metastatic niche: formation, characteristics and therapeutic implication
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Works of Alexandra Savell being referenced
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
2019
A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Alexandra Savell | 142 | 71 | 72 | 111 | 96 | 15 | 237 | |
| H. Yesid Estupiñán | 193 | 63 | 84 | 130 | 56 | 18 | 291 | |
| Fernando Solano | 98 | 53 | 59 | 118 | 62 | 16 | 259 | |
| Giulia Poretti | 112 | 68 | 58 | 143 | 100 | 11 | 280 | |
| Laura Stampleman | 112 | 104 | 29 | 85 | 94 | 17 | 228 | |
| Efstathios Koulieris | 102 | 136 | 45 | 85 | 101 | 22 | 252 | |
| Iryna Kryachok | 125 | 35 | 69 | 121 | 64 | 19 | 190 | |
| Grégory Lazarian | 174 | 39 | 70 | 135 | 54 | 16 | 201 | |
| Shayne Atkinson | 207 | 46 | 68 | 197 | 99 | 11 | 283 | |
| Jean Cheung | 102 | 30 | 39 | 92 | 62 | 15 | 196 | |
| Gandhi Damaj | 78 | 39 | 173 | 78 | 79 | 14 | 280 |
All Works
Loading papers...